Cobicistat (Tybost)
Cytochrome P450 3A Inhibitor class · 0 generic manufacturers · 0 ANDAs filed at FDA.
$391,226 in CY2024 Part D spend1K claims · 238 beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Cobicistat used for?
Cobicistat is tracked in Medicare Part D. Specific indication information is not available in our current dataset.
Is there a generic for Cobicistat?
No. Cobicistat is brand-only with no generic equivalents currently in market.
How much does my plan pay for Cobicistat?
NADAC pricing data not currently available for this drug.
Is Cobicistat on the FDA shortage list?
Cobicistat has been discontinued by its manufacturer(s).
7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.